Schedule 13G ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,381,116
Percent of class
10.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-20-000500
Form type
SC 13G/A
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Feb 07, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub